Mutual Funds
Mutual Funds
Fund Profile
Scheme Profile
Daily NAV
Historical NAV
Category Returns
Dividend Details
Fund Ranking
MF Activities
All Holdings
What's In / What's Out
MF Trends
MF Tools
  Home   >   MUTUAL FUND  >  MUTUAL FUNDS  >  CATEGORY RETURNS
CATEGORY RETURNS      
AMC : Category : Scheme :
Aditya Birla SL Nifty Healthcare ETF
TypeInvestment In% of NAVNo. of sharesValue (Rs cr)
Domestic EquitiesSun Pharmaceutical Industries Limited19.05097843614.1836
Domestic EquitiesDivi's Laboratories Limited8.222294146.1215
Domestic EquitiesDr. Reddys Laboratories Limited8.0214451435.9720
Domestic EquitiesApollo Hospitals Enterprise Limited7.817976225.8205
Domestic EquitiesMax Healthcare Institute Limited7.3522551215.4738
Domestic EquitiesCipla Limited7.3310416775.4580
Domestic EquitiesLupin Limited5.5631179674.1418
Domestic EquitiesFortis Healthcare Limited4.7857386043.5630
Domestic EquitiesTorrent Pharmaceuticals Limited4.355377483.2426
Domestic EquitiesLaurus Labs Limited4.2623288233.1733
Domestic EquitiesAurobindo Pharma Limited3.8648207082.8774
Domestic EquitiesGlenmark Pharmaceuticals Limited3.6051111542.6840
Domestic EquitiesAlkem Laboratories Limited3.143543342.3404
Domestic EquitiesBiocon Limited2.5540528701.9015
Domestic EquitiesMankind Pharma Ltd2.529283811.8830
Domestic EquitiesZydus Lifesciences Limited2.2200185311.6528
Domestic EquitiesIPCA Laboratories Limited2.1155102881.5750
Domestic EquitiesAbbott India Limited1.31523850.9792
Domestic EquitiesPiramal Pharma Ltd0.9980459040.7430
Domestic EquitiesSyngene International Limited0.8830140570.6574
Total 99.9903 74.4438
Cash & Cash Equivalents and Net AssetsClearing Corporation of India Limited0.0403 0.0300
Cash & Cash Equivalents and Net AssetsNet Receivables / (Payables)-0.0306 -0.0228
Total 0.0097 0.0072
 
Back Back TopTop
Disclaimer | Privacy Policy | Grievance | FAQ | Sitemap | Client Registration | Useful Links| Anti Money Laundering | Inactive Client Policy | Scores
Smart ODR Portal | Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Policy on PMLA | Publishing of investor charter information | Annexure A – Investor charter of brokers | Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP | Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure | Details of Research Analyst | UPI QR CODE
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: Click Here.